• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON LABORATORIES IRELAND LTD. CLAREON IOL WITH THE AUTONOME DELIVERY SYSTEM; INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON LABORATORIES IRELAND LTD. CLAREON IOL WITH THE AUTONOME DELIVERY SYSTEM; INTRAOCULAR LENS Back to Search Results
Model Number CNA0T0
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Visual Impairment (2138)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
A healthcare professional reported that following an intraocular lens (iol) implant procedure, the patient experienced unexpected refractive -7.00 d outcome.Additional information has been received that the refractive surprise was -6.50 now more than 1 week post op.The lens was explanted.Additional information has been requested.
 
Additional Manufacturer Narrative
The product was returned for analysis.Power and resolution of the iol was verified and is acceptable.A reading for efl (effective focal length) of 29.011 was obtained.The efl limits for company 13.5d model are: efl min 28.195 to efl max 29.282.The root cause for the reported complaint could not be determined.The sample evaluation confirms that the iol is within the specified resolution and efl ranges for a company lens.Based on the results from the product history record, the products met release criteria.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
Additional information has been received that the patient was doing well with new iol of same power.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLAREON IOL WITH THE AUTONOME DELIVERY SYSTEM
Common Device Name
INTRAOCULAR LENS
Manufacturer (Section D)
ALCON LABORATORIES IRELAND LTD.
cork business&technology park
model farm road
cork 00000
EI  00000
Manufacturer (Section G)
ALCON LABORATORIES IRELAND LTD.
cork business&technology park
model farm road
cork 00000
EI   00000
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key19329920
Report Number9612169-2024-00452
Device Sequence Number14228481
Product Code HQL
UDI-Device Identifier00380652393584
UDI-Public00380652393584
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
P190018
Number of Events Summarized1
Summary Report (Y/N)N
Device Explanted Year2024
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 07/15/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date06/14/2026
Device Model NumberCNA0T0
Device Lot Number25667641
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 04/18/2024
Supplement Date Received by Manufacturer06/17/2024
Initial Report FDA Received Date05/16/2024
Supplement Report FDA Received Date07/15/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured06/16/2023
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention; Other;
Patient SexUnknown
-
-